---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-050194"
form_type: "8-K"
ticker: "MLTX"
cik: "0001821586"
company_name: "MoonLake Immunotherapeutics"
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:59:27.322419+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MoonLake Immunotherapeutics 2024 AGM: all director nominees elected, say-on-pay approved, annual frequency adopted

## Summary
- Director nominees Catherine Moukheibir (50.4M for) and Dr. Ramnik Xavier (53.9M for) elected; 4.24M broker non-votes.
- Baker Tilly ratified as independent auditor with 52.6M for vs 6.4M abstentions.
- Advisory vote on executive compensation passed with 54.7M for (99.99% of votes cast).
- Advisory vote on frequency: 54.2M chose 1 year; company will hold annual say-on-pay votes going forward.

## SEC filing metadata
- accession: 0001213900-24-050194
- form_type: 8-K
- ticker: MLTX
- cik: 0001821586
- company_name: MoonLake Immunotherapeutics
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821586/000121390024050194/0001213900-24-050194-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821586/000121390024050194/ea0207411-8k_moonlake.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-050194
- JSON: https://secwatch.observer/filing/0001213900-24-050194.json
- Plain text: https://secwatch.observer/filing/0001213900-24-050194.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.